CompletedNot Applicable

Effect of the Teleconsultation of Renal Nutrition on Renal Function and Glycemic Control in Patients With DKD

Mexico53 participantsStarted 2017-12-28

Plain-language summary

The modern era is characterized by progress, development and social and economic globalization. Currently the electronic technology has applications in a wide variety of work areas. A clear example of this, is telemedicine. The technological tools are increasingly used every day in the improvement of the processes and the attention in health, in the last decades, telemedicine has grown exponentially becoming more accessible to the population. On the other hand, and in the same way, the number of people with chronic degenerative diseases such as diabetes and chronic kidney disease are increasing with alarming numbers, The health system can not offer the attention to the great demand. The strategies used until now for its management have gradually evolved towards a more effective prevention and treatment approach which requires a multidisciplinary team. Investigate the use of new tools that promise to improve the service, has also become a prevailing need. Therefore, the purpose of this study is to know the effect of nutritional teleconsultation on renal function and glycemic control of patients with Diabetic Kidney Disease (DKD) in pre-dialysis stages (specifically G3a, G3b and G4).

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with diabetic kidney with eGFR \<60 ml / min / 1.73m2 and ≥15 ml / min / 1.73m2, (stage G3a, G3b and G4 respectively). * Patients who can read and write. * Patients who have access to the internet and have a computer, tablet or smartphone. * Patients who signed the voluntary agreement to participate. Exclusion Criteria: * Patients who have received prior nutritional treatment for the control of diabetic kidney disease. * Patients with actual consumption of food supplements and / or keto analogues. * Patients with anemia or recent transfusions (in the last 3 months). * Patients with serious complications (chronic infection, septicemia, cancer, HIV, Alzheimer's, uncontrolled heart failure, liver failure, etc.). * Patients with serious difficulties in communication or intellectual deficit that impedes the ability to understand the intervention. * Patients with refractory arterial hypertension. * Patients who do not attend ≥ 2 nutritional interventions. * Patients who present serious complications during the intervention (chronic infection, septicemia, cancer, HIV, Alzheimer's, uncontrolled heart failure, liver failure, etc.).

What they're measuring

Glycemic Control

Timeframe: Baseline and at 4 month

Renal Function

Timeframe: Baseline and at 4 month

Trial details

NCT IDNCT03344549

SponsorHospital Civil Juan I. Menchaca

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-10-25

Results submitted2022-10-30